Form 4 holding
Chief Operating Officer
RedHill Biopharma Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 218,780,000
- Estimated value
- Report date
- 10 Jul 2026
- Price
- Ownership
- Direct
Gilead Raday
Insider Reports History
- Reporting-owner location
- Tel Aviv
- Latest reporting-owner signature
-
/s/ Gilead Raday
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Gilead Raday
Form 4 holding
Chief Operating Officer
RedHill Biopharma Ltd.
- Security class
- American Depositary Shares
- Shares / value
- 104,130,000
- Estimated value
- Report date
- 10 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Insider Reports Filed by Gilead Raday
4
RDHL
RedHill Biopharma Ltd.
- Report period
- 10 Jul 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 13 Jul 2026, 16:03
- Role
- Chief Operating Officer
- Next action
- Open filing details
4
RDHL
RedHill Biopharma Ltd.
- Report period
- 06 Apr 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 22 Apr 2026, 18:09
- Role
- Chief Operating Officer
- Next action
- Open filing details
3
RDHL
RedHill Biopharma Ltd.
- Report period
- 18 Mar 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 18 Mar 2026, 13:12
- Role
- Chief Operating Officer
- Next action
- Open filing details